Catalyst Wire Dossier Catalyst Wire Dossier

Xofigo (radium-223 dichloride)

radium-223 dichloride · Bayer
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Xofigo (radium-223 dichloride), covering 2024-10-10 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Radium 223 mCRPC-PEACE III [Phase 3]

See pricing